E0 ConsensusPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.
Martínez-Lavín, Manuel, Amezcua-Guerra, Luis · Clinical rheumatology · 2017 · DOI
Quick Summary
This review examined safety reports from HPV vaccine studies and medical databases. The authors found that some large vaccine trials reported more serious side effects in vaccinated groups than in control groups, though researchers did not conclude these were caused by the vaccine. The study raises questions about how thoroughly vaccine safety is monitored and reported.
Why It Matters
This review is relevant to ME/CFS research because post-vaccination symptom clusters reported in case series (including autonomic dysfunction, fatigue, and pain) overlap with ME/CFS symptom profiles. Understanding whether vaccines can trigger or exacerbate ME/CFS-like conditions requires critical examination of safety signals in pre- and post-licensure data, which this study attempts to provide.
Observed Findings
- Bivalent HPV vaccine arm: 14 deaths vs. 3 in aluminum placebo group (p=0.012) over follow-up period
- 9-valent HPV vaccine arm: 3.3% serious systemic adverse events vs. 2.6% in 4-valent group (p=0.01)
- Number needed to harm (9-valent): 140 (95% CI, 79–653)
- Most large RCTs did not use inert placebo in control groups
- Post-marketing case series and VigiBase reports describe similar post-HPV immunization symptom clusters
Inferred Conclusions
- HPV vaccine trials show higher rates of serious adverse events in vaccinated arms than in placebo arms
- The number-needed-to-harm to number-needed-to-vaccinate ratio for 9-valent vaccine is concerning
- Post-marketing surveillance data describe symptom clusters consistent with those observed in RCT safety monitoring
- Investigators' conclusions that SAEs are unrelated to vaccination may warrant independent review
Remaining Questions
- What are the specific post-HPV immunization symptom clusters described in case series, and how do they compare to ME/CFS diagnostic criteria?
- Why did investigators conclude SAEs were not vaccine-related despite statistical significance, and what causality assessment criteria were used?
What This Study Does Not Prove
This review does not prove that HPV vaccines cause ME/CFS or other chronic illnesses, as original trial investigators concluded SAEs were not vaccine-related. The study cannot establish causation from observational case series data alone, and comparison of different placebo types (aluminum vs. inert) limits direct conclusions about vaccine safety. Publication bias and selective reporting in case series further complicate causal inference.
Tags
Symptom:Orthostatic IntoleranceFatigue
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1007/s10067-017-3768-5
- PMID
- 28730271
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →